checkAd
    Startseite > Aktien > Biogen > Nachrichten
    Biogen Aktie
    224,94
     
    USD
    +2,21 %
    +4,87 USD
    Letzter Kurs 02:00:00 Nasdaq
    224,94
     
    USD
    300 STK
    Geldkurs 31.05.24
    225,09
     
    USD
    2.400 STK
    Briefkurs 31.05.24
    ISIN: US09062X1037 · WKN: 789617 · SYM: BIIB · USA ·

    Neueste Nachrichten

    NASDAQ: BIIB: Kessler Topaz Meltzer & Check, LLP Notifies Investors of a Securities Class Action Lawsuit Filed Against Biogen Inc.
    00:03 Uhr · Business Wire (engl.) · Biogen
    Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Biogen Inc. (BIIB) Investors
    31.05.24 · Business Wire (engl.) · Biogen
    Biogen Receives European Commission Approval for QALSODY (tofersen), the First Therapy to Treat a Rare, Genetic Form of ALS
    30.05.24 · globenewswire · Biogen
    INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Biogen Inc. (BIIB) Investors
    30.05.24 · Business Wire (engl.) · Biogen
    The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Biogen Inc. (BIIB) Investors
    30.05.24 · Business Wire (engl.) · Biogen
    BIIB INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Biogen Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
    30.05.24 · Business Wire (engl.) · Biogen
    Biogen Inc. Investor Notice: Robbins LLP Reminds Stockholders of the Class Action Against BIIB
    29.05.24 · Business Wire (engl.) · Biogen
    Biotech Report: Biontech (22UA) und Qiagen (QIA) unter Druck
    28.05.24 · Shareribs · AmgenAnzeige
    Biotech Report: Vita34 (V3V) und Qiagen (QIA) behauptet, US-Sektor klettert
    24.05.24 · Shareribs · AmgenAnzeige
    Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Biogen Inc. (BIIB) Investors
    24.05.24 · Business Wire (engl.) · Biogen
    BIIB INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Biogen Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
    24.05.24 · Business Wire (engl.) · Biogen
    BIIB INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Biogen Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
    23.05.24 · Business Wire (engl.) · Biogen